LFSCNC
0646.819.259 · rovalta.com · 22/09/2026
ACTIVE
LFSCNC
Financial year 2025 · closed on 31/12/2025
Net result
-5,5 k €
-952.8% YoY
Gross margin
-5,2 k €
-2235.3% YoY
Equity
-3,1 k €
-229.1% YoY
Overview
What does LFSCNC do?
LFSCNC is a Private limited company incorporated in 2016. Its main activity is: Activities of holding companies. Its registered office is in Brasschaat.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0646.819.259
Incorporation
20/01/2016
Legal form
Private limited company
Registered office
Door Verstraetelei 28
2930 Brasschaat · FlandreSee on map
2930 Brasschaat · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Activities (NACE)
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||
| Gross margin | -5,2 k € | -2235% | -222,8 € | -197% | 230 € | +125% | 102 € | -53.6% | 219,9 € | +103% | -8,2 k € | -876% | 1,1 k € | +117% | -6,4 k € | -1002% | 708,1 € |
| EBITDA | -5,3 k € | -1463% | -340,8 € | -382% | 121 € | +1209800% | -0 € | -100% | 118,9 € | +101% | -8,3 k € | -963% | 967,3 € | +115% | -6,5 k € | -1085% | 658,1 € |
| Operating result | -5,3 k € | -1463% | -340,8 € | -382% | 121 € | +1209800% | -0 € | -100% | 118,9 € | +101% | -8,3 k € | -963% | 967,3 € | +115% | -6,5 k € | -1085% | 658,1 € |
| Net result | -5,5 k € | -953% | -518 € | 0 € | +100% | -119 € | -1189800% | 0 € | +100% | -8,5 k € | -1155% | 803,6 € | +112% | -6,6 k € | -1722% | 409,1 € | |
| Balance sheet | |||||||||||||||||
| Equity | -3,1 k € | -229% | 2,4 k € | -17.9% | 2,9 k € | 0.0% | 2,9 k € | -3.9% | 3 k € | -35.8% | 4,7 k € | -64.3% | 13,2 k € | +6.5% | 12,4 k € | +16.6% | 10,6 k € |
| Total assets | 12,9 k € | -37.9% | 20,8 k € | -0.1% | 20,8 k € | +2.7% | 20,2 k € | +72.9% | 11,7 k € | +62.2% | 7,2 k € | -83.5% | 43,6 k € | -55.1% | 97,1 k € | +581% | 14,2 k € |
| Cash | 6,5 k € | -22.0% | 8,3 k € | +306% | 2,1 k € | -79.0% | 9,8 k € | +18.2% | 8,3 k € | +36.7% | 6,1 k € | -74.6% | 23,9 k € | -56.6% | 55,1 k € | +1625% | 3,2 k € |
| Debts | 16 k € | -13.1% | 18,4 k € | +2.8% | 17,9 k € | +3.2% | 17,3 k € | +99.5% | 8,7 k € | +246% | 2,5 k € | -91.7% | 30,4 k € | -64.1% | 84,7 k € | +2227% | 3,6 k € |
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 14 ended
Active mandates
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
Andara Therapeutics● Active | 1029.957.579 |
hemalex.bio● Active | 0835.954.116 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/08/2026 | 02/06/2025 | 19/09/2024 | 04/10/2023 | 08/11/2022 | 29/09/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 17/09/2024 | 02/10/2023 | 04/11/2022 | 23/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 17/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 02/06/2025 | 02/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 17/09/2024 | 19/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 02/10/2023 | 04/10/2023 | Dutch | |
| Micro model | 31/12/2021 | 04/11/2022 | 08/11/2022 | Dutch | |
| Micro model | 31/12/2020 | 23/09/2021 | 29/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 02/06/2020 | 10/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 03/06/2019 | 28/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 01/06/2018 | 12/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 01/06/2017 | 13/09/2017 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 14 ended
Active mandates
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-5,5 k €↓
- 2024Annual accounts 2024-518 €↓
- 2023Annual accounts 20230 €↑
- 2023Name changeLFSCNC
- 2022Annual accounts 2022-119 €↓
- 2021Annual accounts 20210 €↑
- 2019Annual accounts 2019-8,5 k €↓
- 2018Annual accounts 2018803,6 €↑
- 2017Annual accounts 2017-6,6 k €↓
- 2016Annual accounts 2016409,1 €
- 20/01/2016IncorporationPrivate limited company
- 2016Name changeHDH CONSULTING